Home Other Building Blocks 2,2-dimethoxy-2-phenylethan-1-amine

2,2-dimethoxy-2-phenylethan-1-amine

CAS No.:
87497-98-1
Catalog Number:
AG01BXP8
Molecular Formula:
C10H15NO2
Molecular Weight:
181.2316
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01BXP8
Chemical Name:
2,2-dimethoxy-2-phenylethan-1-amine
CAS Number:
87497-98-1
Molecular Formula:
C10H15NO2
Molecular Weight:
181.2316
MDL Number:
MFCD19347706
IUPAC Name:
2,2-dimethoxy-2-phenylethanamine
InChI:
InChI=1S/C10H15NO2/c1-12-10(8-11,13-2)9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3
InChI Key:
SNHNHEMULPNHGU-UHFFFAOYSA-N
SMILES:
NCC(c1ccccc1)(OC)OC
Properties
Complexity:
140  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
181.11g/mol
Formal Charge:
0
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
181.235g/mol
Monoisotopic Mass:
181.11g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
44.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. Journal of psychopharmacology (Oxford, England) 20120701
GC-MS and GC-IRD studies on dimethoxyphenethylamines (DMPEA): regioisomers related to 2,5-DMPEA. Journal of chromatographic science 20120101
Synthesis and identification of urinary metabolites of 4-iodo-2,5-dimethoxyphenethylamine. Journal of forensic sciences 20110901
Persistent psychosis after ingestion of a single tablet of '2C-B'. Progress in neuro-psychopharmacology & biological psychiatry 20110115
Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms. Experimental neurobiology 20100901
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion. The neurologist 20100501
Isolation of ugi four-component condensation primary adducts: a straightforward route to isocoumarins. Organic letters 20100219
Morbidity involving the hallucinogenic designer amines MDA and 2C-I. Journal of forensic sciences 20091101
Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicology letters 20080421
Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201
New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. Journal of mass spectrometry : JMS 20060701
Contribution of aldehyde oxidizing enzymes on the metabolism of 3,4-dimethoxy-2-phenylethylamine to 3,4-dimethoxyphenylacetic acid by guinea pig liver slices. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20060101
Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041125
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. British journal of pharmacology 20040401
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. Science & justice : journal of the Forensic Science Society 20020101
Properties